This series of graphics describes the different mechanisms of action that have been proposed for this monoclonal drug therapy. The aim of the therapy is to deplete B cells in order to interrupt several key aspects of an ongoing autoimmune response. The graphics explain the possible mechanisms involved.
View associated Case Study – A 7 year old with severe muscle weakness and difficulty walking
Download Rituximab Mode of Action Guide